Cadila Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADILA, and what generic and branded alternatives to CADILA drugs are available?
CADILA has forty-one approved drugs.
Summary for Cadila
US Patents: | 0 |
Tradenames: | 35 |
Ingredients: | 35 |
NDAs: | 41 |
Patent Litigation for Cadila: | See patent lawsuits for Cadila |
Drugs and US Patents for Cadila
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadila Pharms Ltd | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET;ORAL | 208606-002 | Jan 16, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 218045-002 | Nov 28, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila | GEMFIBROZIL | gemfibrozil | TABLET;ORAL | 204189-001 | Aug 28, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cadila Pharms Ltd | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 211325-003 | May 13, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 208717-002 | Dec 17, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | ACYCLOVIR | acyclovir | TABLET;ORAL | 202168-002 | Nov 15, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila | METRONIDAZOLE | metronidazole | TABLET;ORAL | 206560-001 | Nov 16, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.